[1]秦峰.比较盐酸利托君和阿托班西对35岁以上先兆早产妇女保胎效果、围生儿结局及不良反应发生率的影响[J].中国计划生育和妇产科,2017,(4):68-71.
　QIN Feng.Effect comparison of ritodrine hydrochloride and atosiban on fetus protection, perinatal fetal outcomes and incidence of adverse reactions of threatened premature women aged over 35[J].Chinese Journal of Family Planning & Gynecotokology,2017,(4):68-71.
点击复制

比较盐酸利托君和阿托班西对35岁以上先兆早产妇女保胎效果、围生儿结局及不良反应发生率的影响
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2017年4期
页码:
68-71
栏目:
论著与临床
出版日期:
2017-04-25

文章信息/Info

Title:
Effect comparison of ritodrine hydrochloride and atosiban on fetus protection, perinatal fetal outcomes and incidence of adverse reactions of threatened premature women aged over 35
作者:
秦峰
绵阳市人民医院妇产科
Author(s):
QIN Feng
Department of Obstetrics and Gynecology，Mianyang People 's Hospital，Mianyang Sichuan 621000，P.R. China
关键词:
宫缩抑制剂; 先兆早产; 保胎; 围生儿结局; 不良反应
Keywords:
tocolytic agents;  preterm labor;  fetus protection;  perinatal outcome;  adverse reaction
分类号:
R 714.21
摘要:
目的分析盐酸利托君与阿托西班对≥35岁先兆早产妇女保胎效果、围生儿结局及不良反应发生率的影响。方法选取绵阳市人民医院2014年1月至2015年1月收治的≥35岁的先兆早产妇女共130例，以随机抽签法分为两组各65例，A组予盐酸利托君治疗，B组予阿托西班治疗。比较两组保胎成功率、分娩孕周、低体重儿发生率、新生儿窒息发生率、围生儿死亡率、不良反应发生率、呼吸频率及心率等情况。结果两组保胎成功率、分娩孕周、低体重儿发生率、新生儿窒息发生率及围生儿死亡率比较差异均无统计学意义（P>005）；B组不良反应发生率、用药后呼吸频率和心率、分娩后肌酸激酶同工酶和乳酸脱氢酶水平均显著低于A组，差异有统计学意义（P<005）。结论盐酸利托君与阿托西班治疗≥35岁妇女先兆早产均能取得较好的保胎效果和围生儿结局，但阿托西班安全性更佳。
Abstract:
ObjectiveTo investigate the effect of ritodrine hydrochloride and atosiban on fetus protection, perinatal fetal outcomes and incidence of adverse reactions of threatened premature women aged ≥35. MethodsA total of 130 cases of threatened premature women aged ≥35 years admitted to Mianyang People's Hospital from January 2014 to January 2015 were randomly divided into two groups, with 65 cases each. Group A were treated with ritodrine hydrochloride and group B with atosiban.Fetus protection effects,gestational week,incidence of low birth weight infants,neonatal asphyxia, perinatal mortality, incidence of adverse reactions, respiratory rate and heart rate of both groups were compared. ResultsThere was no significant difference in the fetus protection effects,gestational week,incidence of low birth weight infants,neonatal asphyxia and perinatal mortality between the two groups(P<005）. While incidence of adverse reactions, respiratory rate and heart rate after treatment, levels of creatine kinase isoenzyme(CK-MB) and lactate dehydrogenase (LDH) after pregnancy of group B were significantly lower than that of group A（P<005）. ConclusionBoth ritodrine hydrochloride and atosiban used in the treatment of threatened premature women≥ 35 years old can achieve fetus protection effect and perinatal fetal outcomes, but the safety of atosiban is better.

参考文献/References:

［1］YASUDA R, MAKINO Y, MATSUDA Y, et al Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms ［J］. The Journal of Obstetrics and Gynaecology Research, 2012, 38(3): 574-577. ［2］KIMURA M, KATO T, NOHARA R. Pulmonary edema complicating ritodrine infusion in a patient with premature labor ［J］. Internal Medicine (Tokyo, Japan), 2013, 52(1): 155. ［3］SALIM R, GARMI G, NACHUM Z, et al. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial ［J］. Obstetrics and Gynecology, 2012, 120(6): 1323-1331. ［4］乐杰．妇产科学 ［M］．第7版．北京：人民卫生出版社，2008：86-88． ［5］金菊，方小勤．盐酸利托君与硫酸镁治疗先兆早产的疗效比较及疗效与Creasy高危因素评分的关系 ［J］．现代妇产科进展，2013，22（9）：753-755． ［6］刘晓莉，邹丽颖，陈奕，等．孕产妇年龄对妊娠及分娩结局的影响 ［J］．中华医学杂志，2014，94（25）：1984-1988． ［7］KUC P, LAUDANSKI P, PIERZYNSKI P, et al. The effect of combined tocolysis on in vitro uterine contractility in preterm labour ［J］. Advances in Medical Sciences, 2011, 56(1): 88-94. ［8］NAKAJIMA Y, MASAOKA N, TSUDUKI Y, et al. Rhabdomyolysis caused by tocolytic therapy with oral ritodrine hydrochloride in a pregnant woman with placenta previa ［J］. The Journal of Obstetrics and Gynaecology Research, 2011, 37(6): 629-632. ［9］WEX J, ABOU-SETTA A M, CLERICI G, et al. Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects ［J］. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011, 157(2): 128-135. ［10］HADAR E, MELAMED N, AVIRAM A, et al. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity ［J］. American Journal of Obstetrics and Gynecology, 2013, 209(4): 384.e1-384.e7. ［11］Lan Thi Ngoc Vuong, KHANG V N, GIANG H N, et al. Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure ［J］. Reproductive BioMedicine Online, 2012, 25(3): 254-260. ［12］CHOU Pei-yi, WU M H, PAN H A, et al. Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study ［J］. Taiwanese Journal of Obstetrics & Gynecology, 2011, 50(2): 136-140. ［13］FERNNDEZ A, DOMNGUEZ D, DELGADO L. Severe non-cardiogenic pulmonary oedema secondary to atosiban and steroids ［J］. International Journal of Obstetric Anesthesia, 2011, 20(2): 189-190. ［14］CHEUNG C S, LI T K, LEE C P. Maternal atrial fibrillation after sequential use of nifedipine and atosiban for treatment of preterm labor: case report ［J］. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2013, 166(2): 229.

相似文献/References:

[1]刘媛媛*,李莉,鲁翠萍.先兆早产患者应用抗生素的必要性研究[J].中国计划生育和妇产科,2017,(3):57.
　LIU Yuan-yuan*,LI Li,LU Cui-ping.Study on the necessity of applying antibiotics in patients with threatened preterm labor[J].Chinese Journal of Family Planning & Gynecotokology,2017,(4):57.
[2]周玮,漆洪波*.宫缩抑制剂防治早产的合理选择[J].中国计划生育和妇产科,2018,(11):8.

更新日期/Last Update: 2017-04-25